Clinical Trial Update: Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous breast cancer cells engineered to secrete GM-CSF in metastatic breast cancer; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• autologous breast cancer cells engineered to secrete GM-CSF

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-10-14